ISPE

JULY 19, 2023

The framework conditions for this VUCA world have become more acute: Pandemics and geopolitical events are causing fragile and complex supply chains to collapse. In the convergence, we detect a “picture” of autonomous manufacturing, quality by design, cognitive supply chain, and plug and produce. The upcoming Pharma 4.0™

Documentation 98

Documentation FDA Labelling Communication 98

pharmaphorum

JANUARY 5, 2023

Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better. Ride the technology wave: Technology may ease some challenges associated with a reduced supply of skilled labour.

Communication 90

Communication Pharmaceutical Companies Pharmaceutical Companies 90

Pharmaceutical Technology

JULY 29, 2022

The need for the sector to rapidly research, develop and test new vaccines had always been of critical importance, but in the context of a global pandemic and national lockdowns, it became even more so, with each part of the supply chain required to face up to the full weight of the task. Supply chain resilience: Index score 6.72/10.

Vaccines 59

Vaccines 59

ISPE

MARCH 6, 2023

At the same time, many companies are pursuing localized manufacturing to adjust to supply chain challenges and to improve access to medicine. Moreover, digitalization is increasingly encouraged by regulators as it improves compliance readiness and ensures greater supply chain resiliency.

Communication 97

Communication FDA Pharmaceutical Companies Pharmaceutical Companies 97

Viseven

OCTOBER 26, 2022

Supply Chain Disruptions. It’s hard for us to imagine that a hospital might tell a patient that their treatment needs to be delayed because of a medicine shortage or they are simply unavailable because of logistics challenges in pharmaceutical industry. Planning will help prevent wasted resources.

Hospitals 52

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

NOVEMBER 10, 2022

So called “personalized” treatments with cell therapy include taking cells from a patient, performing the genetic manipulation, and then putting them back into the same patient (autologous); another approach involves supplying modified cells to a pool of patients with a related makeup and disorder (allogeneic). Shin Kawamata, MD, PhD.

Documentation 98

Documentation Compounding Hospitals Immunization 98

ISPE

MARCH 6, 2023

The pharmaceutical industry commits substantial resources in new medicines and treatment options to combat a variety of illnesses and diseases affecting communities globally. Organizations attribute various weight or priority to individual environmental burden types for different, often individual, reasons.

Communication 52

Communication Patient Care 52

pharmaphorum

MAY 23, 2022

“If that resource is widely available, we as the global health funding community can use that data to directly inform what we’re trying to accomplish within an individual programme or funded activity,” Waugaman states. These solutions may also be relevant for government-supported supply chains,” Waugaman states.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

Pharmaceutical Technology

MAY 24, 2023

While both begin with human biological material then seek to edit the cellular genetics and grow the cell population for later transfusion or transplant back into the patient, these two drug categories differ in one highly impactful way affecting the clinical trial supply chain. Differences in CGT vs traditional trials supply chain.

Labelling 98

Labelling Insurance FDA 98

ISPE

MARCH 7, 2023

Research and development, manufacturing, commercial (sales and marketing) activities, and their extended supply chains including logistics are all within this scope. Alternative sources of supply may be sought if suppliers cannot meet their customer expectations. 1 United Nations. 3 Science Based Targets Initiative.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

MARCH 2, 2021

A combination of logistical challenges, supply chain gaps, inconsistent access, and a lack of visibility and data at the administration level has significantly slowed the pace of the rollout everywhere from the United States and Europe to developing countries. Critical supply chain visibility.

Vaccines 118

Vaccines Adverse Reactions Documentation Labelling 118

ISPE

MARCH 7, 2023

This new warehouse and logistics center would provide the much-needed space for continued growth and be vitally important in delivering critical resiliency for facility and logistical operations. The final element entails a renewable clean energy supply. The team accomplished this by introducing an extensive rooftop PV array.

FDA 52

FDA Packaging Documentation 52

European Pharmaceutical Review

SEPTEMBER 16, 2022

We have reported several times on supply chain resilience since the start of the COVID-19 pandemic, 1-3 as the world experienced unprecedented lockdowns and supply disruptions, with interruptions to manufacturing as well as both air transportation and shipping routes. Promoting supply chain localisation.

Packaging 93

Packaging Documentation 93

PharmaShots

JUNE 29, 2023

Founded Year: 2006 Total Employees: ~630 Headquarters: Lysaker, Norway Market Cap: $3.03B Stock Exchange: FRA A biotech innovator and Antarctic krill harvesting company, Aker BioMarine has been developing krill-based nutraceutical products through a secured catch and process chain. Revenue: $277.2M

Immunization 40

Immunization 40

Pharmaceutical Technology

SEPTEMBER 26, 2022

Given the conflict present in the eastern part of Ukraine from 2014, sponsors, investigators and logistics providers were prepared for potential disruption. With patients and staff among those evacuating, resource problems quickly arose. Looking at logistics: Supply chain redesigns have also been implemented.

Packaging 52

Packaging Documentation 52

ISPE

MARCH 15, 2023

1 This view prioritizes steps that reduce the use of natural resources and the release of undesirable products such as carbon to the atmosphere or plastics to landfills. Table 1: Facility environmental sustainability tools and example values. 7 An integrative (vs. 7 An integrative (vs. 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

SEPTEMBER 11, 2023

Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

OCTOBER 27, 2022

This diverse landscape and process-specific supply-chain issues are driving the need for highly flexible facilities that may run multiple products and/or production modes. However, dedicated supply and return corridors are not required. “Viral Vector Platforms Within the Gene Therapy Landscape.”

Packaging 52

Packaging Communication Immunization Vaccines 52

ISPE

MAY 9, 2023

Brazil requires specific forced degradation studies and analytical validation requirements) 1 and require more detail, which may ultimately restrict flexibility for drug supply, at initial registration, and during product life cycle management related to postapproval changes. Some of these are more stringent than ICH requirements (e.g.,

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics).

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

Roots Analysis

DECEMBER 29, 2023

Further, during the COVID 19, many trials were postponed and interrupted due to lockdown, restrictions, prioritization of resources towards COVID 19 studies. Drug Logistics: Currently, a range of technologies and processes are available wherein patients can receive the required medication at their home.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Adverse Reactions 40

pharmaphorum

MARCH 30, 2021

Like other companies, Alexion ensured continuity of supply by increasing stock quantities to make sure the company could manage individual crises on a hospital-by-hospital basis. It made the local organisations feel incredibly secure in their connections with external stakeholders and different hospitals because they knew we could supply.”.

Hospitals 110

Hospitals Communication Pharmaceutical Companies Pharmaceutical Companies 110

Pharmaceutical Technology

MARCH 22, 2023

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Despite having large biopharmaceutical companies on home ground, the UK and France experienced major shortages and supply chain issues.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

JUNE 8, 2023

AstraZeneca has announced its supply chain will be carbon negative by 2030. Supply chains are increasingly in the spotlight. The onset of the Covid-19 pandemic was one catalyst; GlobalData social media analytics suggest supply chains received 1,908 mentions in 2019, compared with 25,636 in 2021.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 52

Pharmaceutical Technology

JANUARY 20, 2023

Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution. As witnessed during the Covid-19 pandemic, when supply chains are disrupted, getting supplies and treatments to patients becomes a major issue.

Pharmaceutical Companies 142

Pharmaceutical Companies Pharmaceutical Companies Packaging Communication 142

Pharmaceutical Technology

MAY 9, 2023

The COVID-19 pandemic and geopolitical instability have put new pressures on the pharmaceutical supply chain. According to Jamaels, when at full capability, it will leverage the power of digital technology to transform the entire value chain. “To The clinical trials landscape is evolving more rapidly than ever before.

Vaccines 52

Vaccines Process Improvement Communication 52